The Enterprise Value as of November 2024 (TTM) for Galmed Pharmaceuticals Ltd. (GLMD) is -5167277.00

According to Galmed Pharmaceuticals Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is -5167277.00. This represents a change of -161.67% compared to the average of 8.38M of the last 4 quarters.

Galmed Pharmaceuticals Ltd. (GLMD) Historical Enterprise Value (quarterly & annually)

How has GLMD Enterprise Value performed in the past?

The mean historical Enterprise Value of Galmed Pharmaceuticals Ltd. over the last ten years is 795.10M. The current -5167277.00 Enterprise Value has changed -164.99% with respect to the historical average. Over the past ten years (40 quarters), GLMD's Enterprise Value was at its highest in in the September 2018 quarter at 3.42B. The Enterprise Value was at its lowest in in the September 2024 quarter at -9249802.50.

Galmed Pharmaceuticals Ltd. (GLMD) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Galmed Pharmaceuticals Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Galmed Pharmaceuticals Ltd. (GLMD) Average Enterprise Value

How has GLMD Enterprise Value performed in the past?

The current Enterprise Value of Galmed Pharmaceuticals Ltd. (GLMD) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Galmed Pharmaceuticals Ltd. (GLMD) Enterprise Value vs. Peers

How is GLMD’s Enterprise Value compared to its peers?

Galmed Pharmaceuticals Ltd.’s Enterprise Value is less than Affimed N.V. (0), less than Abeona Therapeutics Inc. (43.76M), less than Akebia Therapeutics, Inc. (267.34M), less than Kodiak Sciences Inc. (419.45M), less than Mereo BioPharma Group plc (201.31M), less than Adverum Biotechnologies, Inc. (496.22M), less than Adaptimmune Therapeutics plc (106.06M), less than Pieris Pharmaceuticals, Inc. (84.53M), less than PDS Biotechnology Corporation (2.78M), less than Leap Therapeutics, Inc. (53.10M), less than Fortress Biotech, Inc. (35.26M), less than Mustang Bio, Inc. (57.12M), less than Achilles Therapeutics plc (7.08M), greater than Aptose Biosciences Inc. (-38865958.00), less than Fortress Biotech, Inc. (14.43M), less than null (57.12M),

Build a custom stock screener for Galmed Pharmaceuticals Ltd. (GLMD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Galmed Pharmaceuticals Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Galmed Pharmaceuticals Ltd. (GLMD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Galmed Pharmaceuticals Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.